{"id":742692,"date":"2023-03-27T07:05:35","date_gmt":"2023-03-27T11:05:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"},"modified":"2023-03-27T07:05:35","modified_gmt":"2023-03-27T11:05:35","slug":"trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","title":{"rendered":"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023"},"content":{"rendered":"

\nCompany to host a Conference Call & Webcast at 8:00 a.m. ET
\n<\/h2>\n
\n

CHESTERBROOK, Pa., March 27, 2023 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN),<\/strong> a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, prior to the market open on Thursday, March 30, 2023.<\/p>\n

The Company will host a conference call and webcast with the investment community at\u00a08:00 a.m. ET\u00a0that same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Patricia Drake, SVP and Chief Commercial Officer, Mark Demitrack, M.D., SVP and Chief Medical Officer, and Barry Shin, SVP and Chief Financial Officer.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\nTrevena Fourth Quarter & Full Year 2022 Financial Results
Conference Call & Webcast<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\nThursday, March 30, 2023<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Time:<\/strong>\n <\/td>\n8:00 a.m. ET<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\n Conference Call
Details:<\/strong>\n <\/td>\n		Toll-Free: 1-877-704-4453
International: 1-201-389-0920
Conference ID: 13736610<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
The conference call will be webcast live from the Company\u2019s website and will be available via the following links:<\/td>\n<\/tr>\n
\u00a0<\/td>\n<\/tr>\n
\n Webcast:<\/strong>
\n \n <\/td>\n		\n https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1600316&tp_key=4a1d148855<\/a><\/p>\n

https:\/\/www.trevena.com\/investors\/events-presentations\/ir-calendar<\/a>\n <\/td>\n<\/tr>\n

\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company\u2019s website.<\/p>\n

\n About Trevena<\/strong>
\n
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK\u00ae<\/sup>\u00a0(oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company\u2019s novel pipeline is based on Nobel Prize winning research and includes three differentiated investigational drug candidates: TRV045 for diabetic neuropathic pain and epilepsy, TRV250 for the acute treatment of migraine and TRV734 for maintenance treatment of opioid use disorder.<\/p>\n

For more information, please visit\u00a0www.Trevena.com<\/a><\/p>\n

\n For more information, please contact:<\/strong>\n <\/p>\n

\n Investor Contact:<\/strong>
\n
Dan Ferry – Managing Director
LifeSci Advisors, LLC
daniel@lifesciadvisors.com
(617) 430-7576<\/p>\n

\n Company Contact:
<\/strong>Bob Yoder
SVP and Chief Business Officer
Trevena, Inc.
(610) 354-8840<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to host a Conference Call & Webcast at 8:00 a.m. ET CHESTERBROOK, Pa., March 27, 2023 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, prior to the market open on Thursday, March 30, 2023. The Company will host a conference call and webcast with the investment community at\u00a08:00 a.m. ET\u00a0that same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Patricia Drake, SVP and Chief Commercial Officer, Mark Demitrack, M.D., SVP and Chief Medical Officer, and Barry Shin, … <\/p>\n

Continue reading “Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742692","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTrevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Company to host a Conference Call & Webcast at 8:00 a.m. ET CHESTERBROOK, Pa., March 27, 2023 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, prior to the market open on Thursday, March 30, 2023. The Company will host a conference call and webcast with the investment community at\u00a08:00 a.m. ET\u00a0that same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Patricia Drake, SVP and Chief Commercial Officer, Mark Demitrack, M.D., SVP and Chief Medical Officer, and Barry Shin, … Continue reading "Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T11:05:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023\",\"datePublished\":\"2023-03-27T11:05:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\"},\"wordCount\":378,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\",\"name\":\"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==\",\"datePublished\":\"2023-03-27T11:05:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","og_locale":"en_US","og_type":"article","og_title":"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","og_description":"Company to host a Conference Call & Webcast at 8:00 a.m. ET CHESTERBROOK, Pa., March 27, 2023 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022, prior to the market open on Thursday, March 30, 2023. The Company will host a conference call and webcast with the investment community at\u00a08:00 a.m. ET\u00a0that same day, featuring remarks by Carrie Bourdow, President and Chief Executive Officer, Patricia Drake, SVP and Chief Commercial Officer, Mark Demitrack, M.D., SVP and Chief Medical Officer, and Barry Shin, … Continue reading \"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-27T11:05:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023","datePublished":"2023-03-27T11:05:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"},"wordCount":378,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/","name":"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==","datePublished":"2023-03-27T11:05:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NDc0NiM1NDc5NDc2IzUwMDEwMTk4Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-to-release-fourth-quarter-and-full-year-2022-financial-results-on-march-30-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Trevena to Release Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742692"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742692\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}